Early Fever Resolution in Early Childhood Influenza Treated with Baloxavir Marboxil: A Retrospective Study Compared to Those with Oseltamivir

Early Fever Resolution in Early Childhood Influenza Treated with Baloxavir Marboxil: A Retrospective Study Compared to Those with Oseltamivir

<i>Background and Objectives</i>: Baloxavir marboxil is a novel cap-dependent endonuclease inhibitor prescribed for influenza treatment. Unlike neuraminidase inhibitors like oseltamivir, which impair viral release from infected host cells, baloxavir blocks influenza virus proliferation b...

Full description

Bibliographic Details
Main Authors: Keiko Nezu, Shingo Hayashida, Nobuhiko Nagano, Seiichi Udagawa, Ichiro Morioka
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Medicina
Subjects:
cap-dependent endonuclease inhibitor
early childhood
fever
influenza virus
oseltamivir
Online Access:https://www.mdpi.com/1648-9144/59/9/1543

Internet

https://www.mdpi.com/1648-9144/59/9/1543

Similar Items